Insider Selling: 111 (NASDAQ:YI) Director Sells $25,396.80 in Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 115,440 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $0.22, for a total transaction of $25,396.80. Following the sale, the director owned 583,111 shares in the company, valued at approximately $128,284.42. This trade represents a 16.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Thursday, June 11th, Jian David Sun sold 111,100 shares of 111 stock. The stock was sold at an average price of $0.23, for a total transaction of $25,553.00.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total transaction of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The stock was sold at an average price of $0.25, for a total transaction of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Performance

Shares of NASDAQ YI opened at $4.89 on Friday. 111, Inc. Sponsored ADR has a 1 year low of $2.48 and a 1 year high of $11.17. The firm’s 50 day moving average price is $5.92 and its 200 day moving average price is $5.64. The firm has a market cap of $42.96 million, a P/E ratio of -3.49 and a beta of 0.60.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.